| Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Nature medicine 14 (8), 822-827, 2008 | 1114 | 2008 |
| Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases A Yoshizawa, N Motoi, GJ Riely, CS Sima, WL Gerald, MG Kris, BJ Park, ... Modern pathology 24 (5), 653-664, 2011 | 1068 | 2011 |
| Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas SP Gao, KG Mark, K Leslie, W Pao, N Motoi, WL Gerald, WD Travis, ... The Journal of clinical investigation 117 (12), 3846-3856, 2007 | 768 | 2007 |
| EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset K Inamura, K Takeuchi, Y Togashi, S Hatano, H Ninomiya, N Motoi, ... Modern Pathology 22 (4), 508-515, 2009 | 551 | 2009 |
| Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary … N Motoi, J Szoke, GJ Riely, VE Seshan, MG Kris, VW Rusch, WL Gerald, ... The American journal of surgical pathology 32 (6), 810-827, 2008 | 451 | 2008 |
| Programmed death-ligand 1 immunohistochemistry testing: a review of analytical assays and clinical implementation in non-small-cell lung cancer R Büttner, JR Gosney, BG Skov, J Adam, N Motoi, KJ Bloom, M Dietel, ... J clin oncol 35 (34), 3867-3876, 2017 | 392 | 2017 |
| Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: a hospital‐based study K Sunami, H Ichikawa, T Kubo, M Kato, Y Fujiwara, A Shimomura, ... Cancer science 110 (4), 1480-1490, 2019 | 306 | 2019 |
| A grading system for invasive pulmonary adenocarcinoma: a proposal from the International Association for the Study of Lung Cancer Pathology Committee AL Moreira, PSS Ocampo, Y Xia, H Zhong, PA Russell, Y Minami, ... Journal of Thoracic Oncology 15 (10), 1599-1610, 2020 | 290 | 2020 |
| IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy WD Travis, S Dacic, I Wistuba, L Sholl, P Adusumilli, L Bubendorf, P Bunn, ... Journal of Thoracic Oncology 15 (5), 709-740, 2020 | 263 | 2020 |
| An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors D Chitale, Y Gong, BS Taylor, S Broderick, C Brennan, R Somwar, ... Oncogene 28 (31), 2773-2783, 2009 | 253 | 2009 |
| PD-L1 testing for lung cancer in 2019: perspective from the IASLC Pathology Committee S Lantuejoul, M Sound-Tsao, WA Cooper, N Girard, FR Hirsch, AC Roden, ... Journal of Thoracic Oncology 15 (4), 499-519, 2020 | 247 | 2020 |
| Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with … K Kadota, J Villena-Vargas, A Yoshizawa, N Motoi, CS Sima, GJ Riely, ... The American journal of surgical pathology 38 (4), 448-460, 2014 | 244 | 2014 |
| Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study E Thunnissen, MB Beasley, AC Borczuk, E Brambilla, LR Chirieac, ... Modern pathology 25 (12), 1574-1583, 2012 | 243 | 2012 |
| Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities A Yoshida, E Kobayashi, T Kubo, M Kodaira, T Motoi, N Motoi, ... Modern Pathology 30 (6), 797-809, 2017 | 187 | 2017 |
| Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small‐cell lung cancer H Ono, N Motoi, H Nagano, E Miyauchi, M Ushijima, M Matsuura, ... Cancer medicine 3 (3), 632-642, 2014 | 165 | 2014 |
| P-glycoprotein mediates ceritinib resistance in anaplastic lymphoma kinase-rearranged non-small cell lung cancer R Katayama, T Sakashita, N Yanagitani, H Ninomiya, A Horiike, ... EBioMedicine 3, 54-66, 2016 | 158 | 2016 |
| Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo S Takeuchi, A Takahashi, N Motoi, S Yoshimoto, T Tajima, K Yamakoshi, ... Cancer research 70 (22), 9381-9390, 2010 | 157 | 2010 |
| Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin N Motoi, A Sakamoto, T Yamochi, H Horiuchi, T Motoi, R Machinami Pathology-Research and Practice 196 (1), 1-7, 2000 | 153 | 2000 |
| Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide S Homma, A Miyamoto, S Sakamoto, K Kishi, N Motoi, K Yoshimura European respiratory journal 25 (1), 200-204, 2005 | 149 | 2005 |
| The use of immunohistochemistry improves the diagnosis of small cell lung cancer and its differential diagnosis. An international reproducibility study in a demanding set of cases E Thunnissen, AC Borczuk, DB Flieder, B Witte, MB Beasley, JH Chung, ... Journal of thoracic oncology 12 (2), 334-346, 2017 | 140 | 2017 |
William TravisMemorial Sloan Kettering Cancer CenterEmail verificata su mskcc.org
